Strata Critical Medical assumed with a Buy at Lake Street

Lake Street assumed coverage of Strata Critical Medical (SRTA) with a Buy rating and $8 price target Strata has staked out “an intriguing position within the organ transplant ecosystem,” says the analyst, who contends that recent noise around the potential for increased regulations for the industry “will almost certainly accrue to Strata’s benefit.”